Reviewing HTG Molecular Diagnostics (HTGM) and VAREX IMAGING (VREX)
HTG Molecular Diagnostics (NASDAQ: HTGM) and VAREX IMAGING (NASDAQ:VREX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.
This table compares HTG Molecular Diagnostics and VAREX IMAGING’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|HTG Molecular Diagnostics||-432.74%||-1,538.49%||-131.17%|
This is a breakdown of current recommendations for HTG Molecular Diagnostics and VAREX IMAGING, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|HTG Molecular Diagnostics||0||1||2||0||2.67|
HTG Molecular Diagnostics currently has a consensus target price of $6.17, indicating a potential upside of 177.78%. VAREX IMAGING has a consensus target price of $33.50, indicating a potential upside of 15.08%. Given HTG Molecular Diagnostics’ stronger consensus rating and higher probable upside, analysts clearly believe HTG Molecular Diagnostics is more favorable than VAREX IMAGING.
Insider and Institutional Ownership
28.1% of HTG Molecular Diagnostics shares are owned by institutional investors. Comparatively, 91.2% of VAREX IMAGING shares are owned by institutional investors. 7.6% of HTG Molecular Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings and Valuation
This table compares HTG Molecular Diagnostics and VAREX IMAGING’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|HTG Molecular Diagnostics||$5.50 million||3.84||-$20.90 million||($3.01)||-0.74|
|VAREX IMAGING||$654.50 million||1.67||$116.10 million||N/A||N/A|
VAREX IMAGING has higher revenue and earnings than HTG Molecular Diagnostics.
VAREX IMAGING beats HTG Molecular Diagnostics on 6 of the 11 factors compared between the two stocks.
About HTG Molecular Diagnostics
HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company’s HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company’s HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
About VAREX IMAGING
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect. The Medical business segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, radiation therapy and computer-aided detection. The Industrial business segment designs, manufactures, sells and services products for use in security and industrial inspection applications, such as cargo screening at ports and borders and non-destructive examination in a range of applications.
Receive News & Ratings for HTG Molecular Diagnostics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HTG Molecular Diagnostics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.